Elevance Health kicked off 2025 by beating earnings expectations with an EPS of $11.97, flexing its operational muscles ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Elevance posted mixed results for the first quarter but reaffirmed its 2025 earnings outlook, solidifying guidance it published early to pacify investors after UnitedHealth posted dismal results last ...

Supply chain company Owens & Minor released its right to sue over the BlueCard Program by participating in a $2.7 billion ...

The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.

Janelle Zeihen worried she'd have to file for bankruptcy after learning she owed $250,000 for her Crohn's disease treatment.

RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $478.00. The ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health flexed its financial muscles in Q1 2025, reporting a 15.4% jump in revenue to $48.8 billion, driven by ...

The stock's rise snapped a four-day losing streak.

Elevance Health brought in $2.2 billion in profit for the first quarter of 2025, a figure that surpassed Wall Street's ...

Indiana lawmakers have discovered this legislative session that performing major financial surgery on multibillion-dollar ...